Press releaseGlobe Newswire
Sana Biotechnology
SANA · NASDAQ
$2.36+$0.06 (+2.61%)TodayMarket closed ·
Prev close $2.30
Latest news
- Press releasePRNewswire
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates
- Press releasePRNewswire
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releaseGlobe Newswire
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
- Press releasePRNewswire
The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy
- Press releasePRNewswire
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releasePRNewswire
Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum
- Press releaseGlobe Newswire
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
- Press releaseGlobe Newswire
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
- Press releaseGlobe Newswire
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
- NewsVandana Singh
Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race
- NewsRishabh Mishra
Stock Market Today: S&P 500, Nasdaq Futures Rise As JD Vance Touts 'Good Deal' If Iran Meets US 'Red Lines'—Sana, Chevron In Focus (UPDATED)
- NewsAvi Kapoor
Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday
- Press releaseGlobe Newswire
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
- NewsAvi Kapoor
Fastenal, Replimune Group, Children's Place And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- Press releasePRNewswire
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines
- Press releaseGlobe Newswire
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care
- NewsAvi Kapoor
Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday
- Press releasePRNewswire
IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies
- Press releasePRNewswire
Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering
- NewsAvi Kapoor
Dow Dips Over 300 Points; US Initial Claims Rise
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Nasdaq Surges Over 150 Points; ConocoPhillips Earnings Top Estimates
- NewsAvi Kapoor
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
- NewsDavid Pinsen
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes
- Press releasePRNewswire
Flagship Pioneering Unveils Terrana Biosciences to Deliver Adaptive, Targeted Agricultural Solutions through a Novel RNA Technology Platform
- NewsDavid Pinsen
Two Biotech Stocks Poised For Big Moves On Monday
- NewsVandana Singh
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
- Press releaseBusiness Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
- Press releasePRNewswire
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline
- Press releasePRNewswire
Sana Biotechnology, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before May 20, 2025 to Discuss Your Rights - SANA
- Press releasePRNewswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- Press releaseGlobe Newswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.